𝔖 Bobbio Scriptorium
✦   LIBER   ✦

IgD multiple myeloma—a clinical profile and outcome with chemotherapy and autologous stem cell transplantation

✍ Scribed by Ashutosh Wechalekar; Dominic Amato; Chris Chen; A. Keith Stewart; Donna Reece

Publisher
Springer
Year
2004
Tongue
English
Weight
70 KB
Volume
84
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Busulfan, cyclophosphamide, and etoposid
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
✍ Christopher R. Cogle; Jan S. Moreb; Helen L. Leather; Katarzyna J. Finiewicz; Sh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract Autologous stem cell transplantation (ASCT) has enabled the use of high‐dose alkylating agents either as a single agent or in combination with other cytotoxic agents and/or total body irradiation (TBI) for the treatment of multiple myeloma. Despite improved complete remission rates, rel

Cerebral and meningeal multiple myeloma
Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature
✍ Søren L. Petersen; Aase Wagner; Peter Gimsing 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

Meningeal involvement of multiple myeloma is a very rare complication. Defining meningeal myelomatosis (MeM) as the presence of plasma cells in the cerebrospinal fluid in a patient with multiple myeloma, we have found 53 previously reported cases in the literature, where the diagnosis MeM has been m